| Product Code: ETC9964091 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Depression Screening Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Depression Screening Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Depression Screening Market - Industry Life Cycle |
3.4 United States (US) Depression Screening Market - Porter's Five Forces |
3.5 United States (US) Depression Screening Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.6 United States (US) Depression Screening Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 United States (US) Depression Screening Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 United States (US) Depression Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Depression Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of mental health issues in the US |
4.2.2 Growing prevalence of depression and related mental health disorders |
4.2.3 Technological advancements in screening tools and methods |
4.2.4 Supportive government initiatives and policies for mental health screening and treatment |
4.3 Market Restraints |
4.3.1 Stigma associated with mental health issues leading to underreporting and underdiagnosis |
4.3.2 Limited access to mental health services, including screening, in certain regions or populations |
4.3.3 High cost of mental health screenings and treatments |
4.3.4 Lack of trained professionals and resources for widespread screening programs |
5 United States (US) Depression Screening Market Trends |
6 United States (US) Depression Screening Market, By Types |
6.1 United States (US) Depression Screening Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Depression Screening Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 United States (US) Depression Screening Market Revenues & Volume, By Anxiety, 2021- 2031F |
6.1.4 United States (US) Depression Screening Market Revenues & Volume, By Depression, 2021- 2031F |
6.1.5 United States (US) Depression Screening Market Revenues & Volume, By Mood Disorders, 2021- 2031F |
6.1.6 United States (US) Depression Screening Market Revenues & Volume, By Bipolar Disorders, 2021- 2031F |
6.1.7 United States (US) Depression Screening Market Revenues & Volume, By Eating Disorders, 2021- 2031F |
6.1.8 United States (US) Depression Screening Market Revenues & Volume, By Psychotic Disorders, 2021- 2031F |
6.2 United States (US) Depression Screening Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Depression Screening Market Revenues & Volume, By Psychological Test, 2021- 2031F |
6.2.3 United States (US) Depression Screening Market Revenues & Volume, By Depression Screening Tests,, 2021- 2031F |
6.2.4 United States (US) Depression Screening Market Revenues & Volume, By Lab Tests, 2021- 2031F |
6.2.5 United States (US) Depression Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Depression Screening Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Depression Screening Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 United States (US) Depression Screening Market Revenues & Volume, By Deep Brain Stimulation, 2021- 2031F |
6.3.4 United States (US) Depression Screening Market Revenues & Volume, By Brain-Stimulation Treatments, 2021- 2031F |
6.4 United States (US) Depression Screening Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Depression Screening Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.4.3 United States (US) Depression Screening Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.4.4 United States (US) Depression Screening Market Revenues & Volume, By Medical Research Centers, 2021- 2031F |
6.4.5 United States (US) Depression Screening Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Depression Screening Market Import-Export Trade Statistics |
7.1 United States (US) Depression Screening Market Export to Major Countries |
7.2 United States (US) Depression Screening Market Imports from Major Countries |
8 United States (US) Depression Screening Market Key Performance Indicators |
8.1 Percentage increase in the number of individuals seeking depression screenings annually |
8.2 Adoption rate of new technology in depression screening tools |
8.3 Average waiting time for individuals to receive results from depression screenings |
8.4 Percentage of population covered by government-funded mental health screening programs |
8.5 Number of mental health providers trained in depression screening techniques |
9 United States (US) Depression Screening Market - Opportunity Assessment |
9.1 United States (US) Depression Screening Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.2 United States (US) Depression Screening Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 United States (US) Depression Screening Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 United States (US) Depression Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Depression Screening Market - Competitive Landscape |
10.1 United States (US) Depression Screening Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Depression Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here